A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls

Completed · Phase 1

Conditions studied: Renal Impairment

In brief

The purpose of this study is to measure the pharmacokinetics, safety, and tolerability of S-892216 (S-892216-PO) in participants with mild, moderate, or severe renal impairment not on dialysis, or renal impairment requiring hemodialysis (HD), and in participants with normal renal function.

Key facts

Study ID

NCT07217886

Run by

Shionogi

People needed

24

Starts

2025-10-16

Expected to finish

2026-02-13

Last updated by the study team

2026-07-13

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

Where it is running

• Orlando Clicinal Research Center — Orlando, Florida, United States
• Global Clinical Professionals (GCP) LLC — St. Petersburg, Florida, United States
• Genesis Clinical Research — Tampa, Florida, United States
• Alliance for Multispecialty Research (AMR)-Knoxville — Knoxville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.